info icon

This is a non-core endpoint: only basic statistics are computed.

See these related core endpoints for full statistics:

Secondary thrombocytopenia, drug-induced

D3_SCNDTHROMBOCYTOPENIA_ADVERSE

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ATC codes for adverse effects of Drugs ANY
  • Hospital discharge: ICD-10 D69.5#

1 out of 7 registries used, show all original rules.

5

4. Check minimum number of events

None

5

5. Include endpoints

None

5

6. Filter based on genotype QC (FinnGen only)

5

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy
C
First used in FinnGen datafreeze
DF5
Parent code in ICD-10
D69
Name in latin
Thrombocytopenia secundaria

Case counts by codes

FinnGen case counts by registry codes:

Not enough data for upset plot.

Full data table

Summary Statistics

-FinRegistry-

This endpoint is excluded (not available in FinRegistry).

-FinnGen-

Key figures

All Female Male
Number of individuals 5 - -
Unadjusted period prevalence (%) 0.00 - -
Median age at first event (years) 43.46 - -

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

No data available

LabWAS

OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3003338) MCHC [Mass/volume]
5
40
+∞
0.24
28.0
14.8
g/l
328.2
332.8
—
5
40
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
0
10
0.00
0.24
0.0
1.5
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
0
5
0.00
0.00
0.0
8.0
—
98.1
—
0
5
(40768797) Stomach Pathology biopsy report
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
0
7
0.00
0.00
0.0
1.9
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
2.5
—
0.8
—
0
8
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
5
42
+∞
0.00
25.8
14.4
mmol/l
140.4
139.8
—
5
42
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
5
42
+∞
0.00
31.4
14.2
mmol/l
4.1
3.9
—
5
42
(40761511) CBC panel - Blood by Automated count
5
44
+∞
0.00
17.8
12.9
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
0
6
0.00
0.00
0.0
4.7
—
28.7
—
0
6
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
5.8
—
0.2
—
0
5
(3020564) Creatinine [Moles/volume] in Serum or Plasma
5
45
+∞
-0.00
34.2
14.2
umol/l
80.8
70.4
—
5
45

Mortality – FinRegistry

This endpoint is excluded (not available in FinRegistry).

Relationships between endpoints

Index endpoint: D3_SCNDTHROMBOCYTOPENIA_ADVERSE – Secondary thrombocytopenia, drug-induced

GWS hits: -

This endpoint is excluded (not available in FinRegistry).